ATOS Settles Endoxifen Patent Dispute with Intas, Jina; Preserves Z-Endoxifen Development Rights, PTAB Termination Expected
Atossa Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.11
-11% since the alert
$5.77 → $5.11
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS